Seminars in Nephrology
Volume 24, Issue 2 , Pages 115-119, March 2004

AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia

  • Ursula Quitterer

      Affiliations

    • Institut für Pharmakologie, Versbacher Straße 9, Würzburg, D-97078, Germany
    • Corresponding Author InformationAddress reprint requests to Ursula Quitterer, PhD, Institut für Pharmakologie und Toxikologie, Versbacher Straße 9, D-97078 Würzburg, Germany
  • ,
  • Heinz Lother

      Affiliations

    • Heinrich-Pette-Institut, Martinistrasse 52, Hamburg, D-20251, Germany
  • ,
  • Said Abdalla

      Affiliations

    • Medical Research Center (MRC), Ain Shams University Hospital, Cairo, Egypt

Abstract 

Preeclampsia is a pregnancy-specific hypertensive disorder with unknown etiology, which affects 5% to 10% of all pregnancies. Increased sensitivity to the vasoconstrictor angiotensin II is a common feature of preeclampsia, although underlying mechanisms are barely understood. Recent data reveal a potential mechanism for the increased angiotensin II responsiveness in preeclampsia: increased levels of heterodimers between the vasopressor receptor AT1 and the vasodepressor receptor B2. The receptor heterodimers display increased sensitivity toward angiotensin II and are found in platelets and in omental vessels of preeclamptic women. Moreover, AT1/B2 receptor heterodimers are resistant to inactivation by reactive oxygen species, which is elevated in normal and preeclamptic pregnancies. Thus, a major symptom of preeclampsia is the result of complex formation between two G-protein-coupled receptors.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0270-9295(03)00197-9

doi:10.1016/j.semnephrol.2003.11.007

Seminars in Nephrology
Volume 24, Issue 2 , Pages 115-119, March 2004